Bioactive angiotensin peptides

Journal of Human Hypertension

Volumn 12, Issue 5, 1998, Pages 289-293

  Moeller, I ^a   Allen, A M ^a   Chai, S Y ^a   Zhuo, J ^a   Mendelsohn, F A O ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin II (1 7); Angiotensin III; Angiotensin IV; Angiotensin metabolites; Globin

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN RECEPTOR; GLOBIN; NEUROPEPTIDE;

BRAIN; CONFERENCE PAPER; HORMONE METABOLISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0031777187     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000640     Document Type: Conference Paper

References (91)

1. Robertson JIS. Renin and angiotensin: a historical review. In: Robertson JIS, Nicholls MG (eds). The renin-angiotensin system. Gower Medical Publishing: London, 1993, pp 1.1-1.18.
2. Zhuo J et al. The distribution of angiotensin receptors. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, diagnosis and management. Raven Press: New York, 1995, pp 1739-1762.
3. Saavedra JM. Brain and Pituitary angiotensin. Endocr Rev 1992; 13: 329-380.
4. Bottari SP, de Gasparo M, Steckelings UM, Levens NR, Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol 1993; 14: 123-171.
5. Wright JW, Harding JW. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci Biobehav Rev 1994; 18: 21-53.
6. Maric C et al. Effects of angiotensin II on cultured rat renomedullary interstitial cells are mediated by AT1A receptors. Am J Physiol 1996; 271: F1020-F1028.
7. Zhuo J, Alcorn D, Allen AM, Mendelsohn FA. High resolution localization of angiotensin II receptors in rat renal medulla. Kidney Int 1992; 42: 1372-1380.
8. Hall JE, Brands MW. Intrarenal and circulating angiotensin II and renal function. In: Robertson JIS, Nicholls MG (eds). The renin-angiotensin system. Gower Medical Publishing; London, 1993, pp 26.1-26.43.
9. Yamada H et al. Angiotensin II receptors in the kidney. Localization and physiological significance. Am J Hypertens 1990; 3: 250-255.
10. Espiner EA, Nicholls MG. Renin and the control of aldosterone. In: Robertson JIS, Nicholls MG (eds.) The renin-angiotensin system. Gower Medical Publishing: London, 1993, pp 33.1-33.24.
11. Zimmerman BG, Sybertz EJ, Wong PC. Interaction between sympathetic and renin-angiotensin system. J Hypertens 1984; 2: 581-587.
12. Chiu AT, Roscoe WA, McCall DE, Timmermans PBMWM. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells. Receptor 1991; 1: 133-140.
13. Lee Y-A, Lindpainter K. The cardiac renin-angiotensin system. From basic research to clinical relevance. Arzneimittel Forschung 1993; 43: 201-206.
14. Wright JW, Harding JW. Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res Rev 1992; 17: 227-262.
15. Allen AM et al. Angiotensin receptors in the nervous system. Brain Res Bull 1998; (in press).
16. Mendelsohn FAO et al. The brain angiotensin system: Insights from mapping its components. Trends Endocrinol Metab 1990; 1: 189-198.
17. McKinley MJ et al. Circumventricular organs: Neuroendocrine interfaces between the brain and the hernal millieu. Front Neuroendocrinol 1990; 11: 91-127.
18. Bunnemann B, Fuxe K, Ganten D. Extrarenal renin systems: the brain. In: Robertson JIS, Nicholls MG (eds). The renin-angiotension system. Gower Medical Publishing: London, 1993, pp 41.1-41.17.
19. Stoll M et al. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95: 651-657.
20. Gelband CH et al. Functional interactions between neuronal ATI and AT2 receptors. Endocrinol 1997; 138: 2195-2198.
21. Semple PF, Boyd AS, Dawes PM, Morton JJ. Angiotensin II and its heptapeptide (2-8), hexapeptide (3-8), and pentapeptide (4-8) metabolites in arterial and venous blood of man. Circ Res 1976; 39: 671-678.
22. 125I]angiotensins in rat. J Neurochem 1986; 46: 1292-1297.
23. Zini S et al. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: Predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci 1996; 93: 11968-11973.
24. Tonnaer JADM et al. Proteolytic conversion of angiotensins in rat brain tissue. Eur J Biochem 1983; 131: 415-421.
25. Welches WR et al. Evidence that prolyl endopeptidase participates in the processing of brain angiotensin. J Hypertens 1991; 9: 631-638.
26. Neves LAA, Almeida AP, Khosla MC, Santos RAS. Metabolism of angiotensin I in isolated rat hearts. Effect of angiotensin converting enzyme inhibitors. Biochem Pharmacol 1995; 50: 1451-1459.
27. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neural endopeptidase 24.11 Life Sci 1993; 52: 1461-1480.
28. Pendleton RG, Gessner G, Homer E. Studies defining minimal receptor domains for angiotensin II. J Pharmacol Exp Ther 1989; 250: 31-36.
29. Blair-West JR et al. The effect of the heptapeptide (2-8) and hexapeptide (3-8) fragments of angiotensin II on aldosterone secretion. J Clin Endocrinol Metab 1971; 32: 575-578.
30. Fitzsimons JT. The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon. J Physiol 1971; 214: 295-303.
31. Caldicott WJH, Taub KJ, Hollenberg NK. Identical mesenteric, femoral and renal vascular responses to angiotensins II and III in the dog. Life Sci 1977; 20: 517-522.
32. Wright JW et al. Central angiotensin III-induced dipsogenicity in rats and gerbils. Brain Res 1984; 295: 121-126.
33. Wright JW et al. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats. Brain Res 1990; 514: 5-10.
34. Harding JW, Felix D. Angiotensin-sensitive neurons in the rat paraventricular nucleus: relative potencies of angiotensin II and angiotensin III. Brain Res 1987; 410: 130-134.
35. Tonnaer JADM, Wiegant VM, De Jong W, De Wied D. Central effects of angiotensins on drinking and blood pressure: structure-activity relationships. Brain Res 1982; 236: 417-428.
36. Schiavone MT et al. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci 1988; 85: 4095-4098.
37. Felix D et al. Neurophysiological responses to angiotensin-(1-7). Hypertension 1991; 17: 1111-1114.
38. Barnes KL, Knowles WD, Ferrario CM. Angiotensin II and angiotensin (1-7) excite neurons in the canine medulla in vitro. Brain Res Bull 1990; 24: 275-280.
39. Santos RA, Campagnole Santos MJ. Central and peripheral actions of angiotensin-(1-7). Braz J Med Biol Res 1994; 27: 1033-1047.
40. Fontes MA et al. Evidence that angiotensin-(1-7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors. Brain Res 1994; 665: 175-180.
41. Fontes MA et al. Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats. Brain Res 1997; 50: 305-310.
42. Moriguchi A et al. Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension 1995; 25: 1260-1265.
43. Porsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol 1994; 111: 652-654.
44. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996; 27: 523-528.
45. Osei SY et al. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol 1993; 234: 35-42.
46. Jaiswal N et al. Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am J Physiol 1991; 260: R1000-R1006.
47. Jaiswal N et al. Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension 1991; 17: 1115-1120.
48. Jaiswal N et al. Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors. Hypertension 1992; 19: II49-II55.
49. Jaiswal N et al. Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension 1993; 21: 900-905.
50. Jaiswal N et al. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. J Pharmacol Exp Ther 1993; 265: 664-673.
51. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996; 28: 104-108.
52. Tallant EA, Higson JT. Angiotensin II activates distinct signal transduction pathways in astrocytes isolated from neonatal rat brain. Glia 1997; 19: 333-342.
53. Freeman EJ, Ferrario CM, Tallant EA. Angiotensins differentially active phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. Am J Hypertension 1995; 8: 1105-1111.
54. Freeman EJ, Tallant EA. Vascular smooth-muscle cells contain ATI angiotensin receptors coupled to phospholipase D activation. Biochem J 1994; 304: 543-548.
55. Andreatta-van-Leyen S, Romero MF, Khosla M, Douglas JG. Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7). Kidney Int 1993; 44: 932-936.
56. Swanson GN et al. Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul Pept 1992; 40: 409-419.
57. DeGasparo M et al. Proposed Update of Angiotensin Receptor Nomenclature. Hypertension 1995; 25: 924-927.
58. Harding JW et al. Identification of an AII(3-8)[AIV] binding site in guinea pig hippocampus. Brain Res 1992; 583: 340-343.
59. Miller Wing AV et al. Central angiotensin IV binding sites: distribution and specificity in guinea pig brain. J Pharmacol Exp Ther 1993; 266: 1718-1726.
60. Hanesworth JM et al. Elucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes. J Pharmacol Exp Ther 1993; 266: 1036-1042.
61. Hall KL et al. Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV. Regul Pept 1993; 44: 225-232.
62. Hall KL et al. Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul Pept 1995; 58: 107-115.
63. Moeller I et al. Distribution of AT4 receptors in the Macaca fascicularis brain. Brain Res 1996; 712: 307-324.
64. Bernier SG, Fournier A, Guillemette G. A specific binding site recognizing a fragment of angiotensin II in bovine adrenal cortex membranes. Eur J Pharmacol 1994; 271: 55-63.
65. Wright JW, Krebs LT, Stobb JW, Harding JW. The angiotensin IV system: functional implications. Front Neuroendocrinol 1995; 16: 23-52.
66. Braszko JJ, Kupryszewski G, Witczuk B, Wisniewski K. Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats. Neurosci 1988; 27: 777-783.
67. Wright JW et al. Angiotensin II(3-8)(Ang IV) hippocampal binding: potential role in the facilitation of memory. Brain Res Bull 1993; 32: 497-502.
68. Roberts KA et al. Audoradiographic identification of brain angiotensin IV binding sites and differential c-FOS expression following intracerebroventricular injection of angiotensin II and IV in rats. Brain Res 1995; 682: 13-21.
69. Moeller I et al. Angiotensin IV inhibits neurite outgrowth in cultured embryonic chicken sympathetic neurons. Brain Res 1996; 725: 61-66.
70. Haberl RL, Decker PJ, Einhaupl KM. Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ Res 1991; 68: 1621-1627.
71. Naveri L, Stromberg C, Saavedra JM. Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat. J Cereb Blood Flow Metab 1994; 14: 1096-1099.
72. Gardiner SM, Kemp PA, March JE, Bennett T. Regional haemodynamic effects of angiotensin II (3-8) in conscious rats. Br J Pharmacol 1993; 110: 159-162.
73. Cheng DY et al. Analysis of responses to angiotensin IV in the pulmonary vascular bed of the cat. Eur J Pharmacol 1994; 261: 223-227.
74. Nossaman BD, Feng CJ, Kaye AD, Kadowitz PJ. Analysis of responses to Ang IV: effects of PD-123319 and Dup-753 in the pulmonary circulation of the rat. Am J Physiol 1995; 268: L302-L308.
75. Garrison EA, Santiago JA, Osei SY, Kadowitz PJ. Analysis of responses to angiotensin peptides in the hindquarters vascular bed of the cat. Am J Physiol 1995; 268: H2418-H2425.
76. Li Q, Zhang L, Pfaffendorf M, van Zwieten PA. Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta. Br J Pharmacol 1995; 116: 2963-2970.
77. Kerins DM, Hao Q, Vaughan DE. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 1995; 96: 2515-2520.
78. Pawlikowski M, Kunert Radek J. Angiotensin IV stimulates the proliferation of rat anterior pituitary cells in vitro. Biochem Biophys Res Commun 1997; 232: 292-293.
79. Wang L, Eberhard M, Kohler E, Erne P. A specific binding site for angiotensin II(3-8), angiotensin IV, in rabbit cardiac fibroblasts. J Recept Signal Transduct Res 1995; 15: 517-527.
80. 1]-angiotensin IV reduces mechanically induced immediate early gene expression in the isolated rabbit heart. Rebul Pept 1997; 71: 175-183.
81. Ransom JT et al. ATI angiotensin receptors mobilize intracellular calcium in a subclone of NG108-15 neuroblastoma cells. J Neurochem 1992; 58: 1883-1888.
82. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 1990; 259: H610-H618.
83. Dostal DE, Murahashi T, Peach MJ. Regulation of Cytosolic Calcium by Angiotensins in Vascular Smooth Muscle. Hypertension 1990; 15: 815-822.
84. Dulin N et al. Angiotensin IV receptors and signaling in opossum kidney cells. Am J Physiol 1995; 269: F644-F652.
85. Moeller I et al. The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT4 receptor in the brain. J Neurochem 1997; 68: 2530-2537.
86. Chang RCC et al. Isolation and structure of several peptides from porcine hypothalami. Biochimica Biophysica Acta 1998; 625: 266-273.
87. Barkhudaryan N, Oberthuer W, Lottspeich F, Galoyan A. Structure of hypothalamic coronaro-constrictory peptide factors. Neurochem Res 1992; 17: 1217-1221.
88. Glamsta EL et al. Isolation and characterization of a hemoglobin-derived opioid peptide from the human pituitary gland. Regul Pept 1991; 34: 169-179.
89. Karelin AA, Philippova MM, Karelina EV, Ivanov VT. Isolation of endogenous hemorphin-related hemoglobin fragments from bovine brain. Biochem Biophys Res Commun 1994; 202: 410-415.
90. Piot JM et al. Isolation and characterization of two opioid peptides from a bovine hemoglobin peptic hydrolyate. Biochem Biophys Res Commun 1992; 189: 101-110.
91. Barkhudaryan N, Kellermann J, Galoyan A, Lottspeich F. High molecular weight aspartic endopeptidase generates a coronaro-constrictory peptide from the b-chain of hemoglobin. FEBS Letters 1993; 329: 215-218.